Surveillance in Stage I Seminoma Patients: A Long-Term Assessment

European Urology

Volumn 57, Issue 4, 2010, Pages 673-678

  Cummins, Sebastian ^a   Yau, Thomas ^b   Huddart, Robert ^c   Dearnaley, David ^c   Horwich, Alan ^c  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Management; Outcomes; Seminoma; Testis cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; EARLY CANCER; HUMAN; MALE; ORCHIECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; SEMINOMA;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; ENGLAND; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORCHIECTOMY; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEMINOMA; TESTICULAR NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WATCHFUL WAITING; YOUNG ADULT;

EID: 77249114673     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.06.006     Document Type: Article

References (31)

1. Hamilton C.A.H., Easton A., and Peckham M.J. Radiotherapy for stage I seminoma testis: results of treatment and complications. Radiother Oncol 6 (1986) 115-120
2. Oliver R.T., Mason M.D., Mead G.M., et al. Radiotherapy versus single dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366 (2005) 293-300
3. Jones W.G., Fossa S.D., Mead G.M., et al. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 23 (2005) 1200-1208
4. Fossa S.D., Aass N., and Kaalhus O. Radiotherapy for testicular seminoma stage I: treatment results and long-term post irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 16 (1989) 383-388
5. Horwich A. Radiotherapy in stage I seminoma of the testis. J Clin Oncol 22 (2004) 585-588
6. Boyer M., and Raghavan D. Toxicity of treatment of germ cell tumours. Semin Oncol 19 (1992) 128-142
7. Bokemeyer C., and Schmoll H.-J. Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol 13 (1995) 283-292
8. Moynihan C. Psychosocial assessments and counselling of the patient with testicular cancer. In: Horwich A. (Ed). Testicular cancer clinical investigation and management (1991), Chapman and Hall Medical, London, UK 353-368
9. Schover L. Sexual and marital relations after radiotherapy for seminoma. Urology 27 (1986) 117-123
10. Travis L.B., Fosså S.D., Schonfeld S.J., et al. Second cancers among 40576 testicular cancer patients: focus on long term survivors. J Natl Cancer Inst 97 (2005) 1354-1365
11. Zagars G.K., and Pollack A. Radiotherapy for stage II testicular seminoma. J Clin Oncol 22 (2004) 640-647
12. Huddart R.A., Norman A., Shahidi M., et al. Cardiovascular disease as along term complication of treatment for testicular cancer. J Clin Oncol 21 (2003) 1513-1523
13. Horwich A., and Peckham M.J. Surveillance after orchidectomy for clinical stage I germ cell tumours of the testis. Prog Clin Biol Res 269 (1988) 471-479
14. Peckham M.J., Barret A., Horwich A., and Hendry W.F. Orchidectomy alone for stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. Br J Urol 55 (1983) 754-759
15. Horwich A., Alsanjari N., Hern R.A., Nicholls J., Dearnaley D.P., and Fisher C. Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 65 (1992) 775-778
16. Warde P., Gospodarowicz M.K., Panzarella T., et al. Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol 13 (1995) 2255-2262
17. von der Masse H., Specht L., Jacobsen G.K., et al. Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 29A (1993) 1931-1934
18. Warde P., Specht L., Horwich A., et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20 (2002) 4448-4452
19. Krege S., Beyer J., Souchon R., et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part 1. Eur Urol 53 (2008) 478-496
20. Patterson H., Norman A.R., Mitra S.S., et al. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Radiother Oncol 59 (2001) 5-11
21. Duchesne G.M., Horwich A., Dearneley D.P., et al. Orchidectomy alone for stage I seminoma of the testis. Cancer 65 (1990) 1115-1118
22. Allhoff E.P., Liedke S., de Riese W., Stief C., and Schneider B. Stage I seminoma of the testis. Adjuvant radiotherapy or surveillance?. Br J Urol 68 (1991) 190-194
23. Classen J., Schmidberger H., Meisner C., et al. Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol 21 (2003) 1101-1106
24. Chung P.W.M., Gospodarowicz M.K., Panzarella T., et al. Stage II testicular seminoma: patterns of recurrence and outcome of treatment. Eur Urol 45 (2004) 754-760
25. Krege S., Boergermann C., and Hinke A. Single agent carboplatin for CS11A/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG). Ann Oncol 17 (2006) 276-280
26. Aparicio J., Germa J.R., Garcia del Muro X., et al. Risk adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 23 (2005) 8717-8723
27. Read G., Stenning S.P., Cullen M.H., et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 10 (1992) 1762-1768
28. Lippert M.C., and Javadpour N. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer. Cancer 48 (1981) 2274-2278
29. Munro A.J., Nielsen O.S., Duncan W., et al. An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta HCG). Br J Cancer 64 (1991) 537-542
30. Huddart R.A., O'Doherty M.J., Padhani, et al. 18 Fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumours: preliminary report of MRC trial TE22-the NCRI Testis Tumour Clinical Study Group. J Clin Oncol 25 (2007) 3090-3095
31. Moynihan C, Norman AR, Barbachano Y, et al. A prospective study of factors predicting adherence to medical advice in men with testicular cancer. J Clin Oncol. In press.